Chinese scientist makes quality visit to USP; DPT overhauls Sterile & Specialty plant in NJ;

> Under its visiting scientist program for quality standards, the U.S. Pharmacopeial Convention is hosting Minghao Zhou from China's Zhejiang Provincial Institute for Food & Drug Control. Article

> A micro-lab and Class A filling suites, Class B and C support suites, and Class D component-prep areas are part of a $30 million expansion and infrastructure overhaul to DPT Laboratories' Center of Excellence for Sterile & Specialty Products in Lakewood, N.J. Release

> Roche NimbleGen, part of the drug giant's diagnostic division, is taking a GMP approach to its high-density DNA microarrays in an effort that will span development through manufacturing. Release

> The Ceelox ID Server, a network biometric security solution that works in conjunction with Honeywell POMS and Citrix, aims at "precise and automated processing and control" in pharma manufacturing ops. Release

> Zimbabwe's only listed pharmaceutical company, CAPS, has resumed production at its refurbished plant in Harare. Article

 

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.